Indoco Remedies has successfully cleared Malta Medicines Authority audit. The Malta Medicines Authority had inspected the company’s manufacturing facility for solid oral dosage form (Unit I) located at Baddi from January 29, 2026, to February 3, 2026. The facility has received EU GMP certification from the Malta Medicines Authority confirming that it complies with the Good Manufacturing Practice requirements as referred in the EC Directive.
Indoco Remedies is engaged in the manufacturing and marketing of formulations (finished dosage forms) and active pharmaceutical ingredients (APIs) in India.